✦ LIBER ✦

Metabolically active liver metastases treated by 5-fluorouracil hepatic artery infusion

✍ Scribed by Edward Earle; Donald Butts; Lester L. Hoaglin Jr

Publisher: John Wiley and Sons
Year: 1970
Tongue: English
Weight: 319 KB
Volume: 25
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197005)25:5<1170::aid-cncr2820250522>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regional chemotherapy for colorectal liv

Regional chemotherapy for colorectal liver metastases: A phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases

✍ Miss J. A. Goldberg; D. J. Kerr; N. Wilmott; J. H. McKillop; C. S. McArdle 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB 👁 2 views

Results of pharmacokinetic modulating ch

Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases

✍ Masato Kusunoki; Hidenori Yanagi; Masafumi Noda; Reigetsu Yoshikawa; Takehira Ya 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## BACKGROUND. Pharmacokinetic modulating chemotherapy (PMC) is a new therapeutic concept in combination with continuous 5-fluorouracil (5-FU) infusion and UFT. UFT enhanced plasma 5-FU concentration and antitumor effects during 5-FU infusion. The authors report on their experiences with arterial

Disposition of 5-fluorouracil during chr

Disposition of 5-fluorouracil during chronic hepatic arterial infusion to patients with carcinoma in the liver and effect on circulating platelets

✍ Daniel S. Sitar; John R. Ruedy; Douglas H. Shaw Jr.; Andrew W. Maksymiuk; Michae 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 2 views

## Abstract 5‐Fluorouracil was administered by continuous hepatic intra‐arterial infusion to eight patients with the diagnosis of cancer of the gastrointestinal tract and hepatic metastases. Its elimination characteristics were investigated to see if they correlated with therapeutic effect or reduc

Severe, symptomatic, dose-limiting hypop

Severe, symptomatic, dose-limiting hypophosphatemia induced by hepatic arterial infusion of recombinant tumor necrosis factor in patients with liver metastases

✍ Auro Del Giglio; Giora M. Mavligit; Alexander A. Zukiwski; Mohamed K. Ali 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

Twenty-two patients with liver metastases received 45 courses of recombinant tumor necrosis factor (rTNF] by hepatic arterial infusion in doses ranging from 12.5 to 175 pg/m2/d for 5 days by continuous infusion. The induction of statistically significant, dose-related, severe, albeit transient, hypo